platelet-derived growth factor-D mAbs (CuraGen/Amgen)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameplatelet-derived growth factor-D mAbs (CuraGen/Amgen)
Drug Alias NameCR-002.6.4PDGF-D mAbs (CuraGen/Abgenix)platelet-derived growth factor-D mAbs (CuraGen/Abgenix)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionPlatelet-derived growth factor receptor inhibitors
TargetsPlatelet-derived growth factor receptor
Therapy Area/IndicationsInflammationCardiovascular DiseasesKidney Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCuraGen Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCuraGen CorpAmgen IncAbgenix Incorporated
Active IndicationsN/A
Inactive IndicationsInflammationCardiovascular DiseasesKidney Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A